Benchmark C · Consolidation & Intercompany
Multi-Entity Consolidation Bridge & Intercompany Netting Matrix
Hierarchical subsidiary trial balance aggregation, ASC 830 / IAS 21 currency remeasurement, and automated bilateral elimination of reciprocal balances.
ILLUSTRATIVE PRODUCT SCENARIO
Consolidated Legal Entities
4 Operating + 1 Holding
100% Fully Consolidated
Eliminated Intercompany
$13,487,500
Uneliminated: $1,362,500
CTA Currency Reserve
$3.84M USD
ASC 830 Cumulative Translation
Consolidated Net Revenue
$184.5M USD
Post-Intercompany Elimination
Presentation Currency:
Bilateral Intercompany Elimination Matrix (USD Thousands)
| Entity From \ To | ENT-101 (NA) | ENT-201 (EU) | ENT-301 (APAC) | ENT-401 (UK) | Net Bilateral Variance |
|---|---|---|---|---|---|
| ENT-101 (North America) | — | $0.0* | $2,450.0 | $820.0 | -$1,362.5 |
| ENT-201 (Europe B.V.) | $1,362.5 | — | $1,890.0 | $3,400.0 | +$1,362.5 |
| ENT-301 (Asia-Pacific) | $2,450.0 | $1,890.0 | — | $1,120.0 | $0.0 ✓ |
| ENT-401 (UK Treasury) | $820.0 | $3,400.0 | $1,120.0 | — | $0.0 ✓ |
Reciprocal Netting Notice: ENT-201 recorded EUR 1,250,000 ($1,362,500 USD) due from ENT-101 under IC-INV-2026-884, but ENT-101 has not committed the matching reciprocal voucher. Intercompany elimination is unbalanced until Gate 4 resolution.
Consolidation Bridge & Segment Contribution (FY2026-M08)
1. Aggregated Trial Balance
$468,287,500
Sum of 4 Operating Subsidiaries
2. FX Remeasurement / CTA
+$3,840,000
Equity Translation Reserve
3. Intercompany Elimination
-$13,487,500
Reciprocal IC Receivables/Payables
4. Group Consolidated Assets
$454,800,000
Audited Disclosure Readiness